Former AXA Framlington Biotechnology fund manager Andy Smith has joined biopharma specialist Mann Bioinvest to launch an income-focused fund in the coming weeks.
The Magna BioPharma Income fund, slated to launch around the end of Q1 2013, will be managed by Smith, with key decisions overseen by an investment committee. Boutique equity house Charlemagne Capital...
More launches planned for 2019
Assessing the impact of the vote
Annual Mansion House speech
Knockout contest by measuring each country's growth forecast
Added to MSCI Emerging Markets index